Rob Maloney: A Bruise that Did Not Go Away…
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”A bruise that didn’t go away.
A teenager playing baseball took a hard shot to the thigh.
There was a bruise and some swelling. Nothing unusual.
Except it didn’t go away.
A week passed. Then two. Still swollen and painful.
Doctor after doctor. Then the words no parent expects to hear: Hemophilia.
Years of their son’s life instantly reframed.
How did we miss this?
What if he’d hit his head instead?
What happens next time?
And for his mom, a deeper sentence she could barely get out:
“I didn’t know I was a carrier.”
If you’ve walked near this world, you know the emotional terrain.
Fear and guilt. Confusion and overwhelmed.
This is the part of healthcare you’ll never see on an organizational chart or in a claim file.
It’s the human weight behind every rare diagnosis.
When that family eventually landed with Hemophilia of Georgia, everything shifted.
Our nurse and social worker didn’t start with paperwork, but with presence.
• Home infusion training
• What to do before the next dental procedure or surgery
• Insurance navigation
• Education on the disease
• Scholarships and long-term support
• Space for a mom to ask every question she’d been holding in
This wasn’t a quick discharge and a follow-up call.
It was wraparound care. Clinical, emotional, and practical.
That moment taught me something I haven’t forgotten.
A rare diagnosis requires a rare kind of support.
And when it happens, families shouldn’t feel like they’re walking through it alone.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026